TY - JOUR AU - Wimo, A. AU - Jonsson, L. AU - Bond, J. AU - Prince, M. AU - Winblad, B. PY - 2013 DA - 2013// TI - Alzheimer Disease International. The worldwide economic impact of dementia 2010 JO - Alzheimers Dement VL - 9 UR - https://doi.org/10.1016/j.jalz.2012.11.006 DO - 10.1016/j.jalz.2012.11.006 ID - Wimo2013 ER - TY - JOUR AU - McKhann, G. AU - Drachman, D. AU - Folstein, M. AU - Katzman, R. AU - Price, D. AU - Stadlan, E. M. PY - 1984 DA - 1984// TI - Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease JO - Neurology. VL - 34 UR - https://doi.org/10.1212/WNL.34.7.939 DO - 10.1212/WNL.34.7.939 ID - McKhann1984 ER - TY - JOUR AU - Jack, C. R. AU - Knopman, D. S. AU - Jagust, W. J. AU - Petersen, R. C. AU - Weiner, M. W. AU - Aisen, P. S. PY - 2013 DA - 2013// TI - Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers JO - Lancet Neurol. VL - 12 UR - https://doi.org/10.1016/S1474-4422(12)70291-0 DO - 10.1016/S1474-4422(12)70291-0 ID - Jack2013 ER - TY - JOUR AU - Bartus, R. T. PY - 2000 DA - 2000// TI - On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis JO - Exp Neurol. VL - 163 UR - https://doi.org/10.1006/exnr.2000.7397 DO - 10.1006/exnr.2000.7397 ID - Bartus2000 ER - TY - JOUR AU - Bartus, R. T. AU - Dean, R. L. AU - Beer, B. AU - Lippa, A. S. PY - 1982 DA - 1982// TI - The cholinergic hypothesis of geriatric memory dysfunction JO - Science. VL - 217 UR - https://doi.org/10.1126/science.7046051 DO - 10.1126/science.7046051 ID - Bartus1982 ER - TY - JOUR AU - Davies, P. AU - Maloney, A. J. PY - 1976 DA - 1976// TI - Selective loss of central cholinergic neurons in Alzheimer’s disease JO - Lancet. VL - 8000 UR - https://doi.org/10.1016/S0140-6736(76)91936-X DO - 10.1016/S0140-6736(76)91936-X ID - Davies1976 ER - TY - JOUR AU - Bartus, R. T. PY - 1978 DA - 1978// TI - Evidence for a direct cholinergic involvement in the scopolamine induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine JO - Pharmacol Biochem Behav. VL - 9 UR - https://doi.org/10.1016/0091-3057(78)90364-7 DO - 10.1016/0091-3057(78)90364-7 ID - Bartus1978 ER - TY - JOUR AU - Doody, R. S. AU - Dunn, J. K. AU - Clark, C. M. AU - Farlow, M. AU - Foster, N. L. AU - Liao, T. PY - 2001 DA - 2001// TI - Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer’s disease JO - Dement Geriatr Cogn Disord. VL - 12 UR - https://doi.org/10.1159/000051272 DO - 10.1159/000051272 ID - Doody2001 ER - TY - JOUR AU - Ness, S. AU - Rafii, M. AU - Aisen, P. AU - Krams, M. AU - Silverman, W. AU - Manji, H. PY - 2012 DA - 2012// TI - Down’s syndrome and Alzheimer’s disease: towards secondary prevention JO - Nat Rev Drug Discov. VL - 11 UR - https://doi.org/10.1038/nrd3822 DO - 10.1038/nrd3822 ID - Ness2012 ER - TY - JOUR AU - Jonsson, T. AU - Atwal, J. K. AU - Steinberg, S. AU - Snaedal, J. AU - Jonsson, P. V. AU - Bjornsson, S. PY - 2012 DA - 2012// TI - A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline JO - Nature. VL - 488 UR - https://doi.org/10.1038/nature11283 DO - 10.1038/nature11283 ID - Jonsson2012 ER - TY - JOUR AU - Maccioni, R. B. AU - Lavados, M. AU - Maccioni, C. B. AU - Mujica, C. AU - Bosch, R. AU - Farías, G. PY - 2006 DA - 2006// TI - Anomalously phosphorylated tau protein and Abeta fragments in the CSF of Alzheimer’s and MCI subjects JO - Neurobiol Aging. VL - 27 UR - https://doi.org/10.1016/j.neurobiolaging.2005.01.011 DO - 10.1016/j.neurobiolaging.2005.01.011 ID - Maccioni2006 ER - TY - JOUR AU - Okamura, N. AU - Harada, R. AU - Furumoto, S. AU - Arai, H. AU - Yanai, K. AU - Kudo, Y. PY - 2014 DA - 2014// TI - Tau PET imaging in Alzheimer’s disease JO - Curr Neurol Neurosci Rep. VL - 14 UR - https://doi.org/10.1007/s11910-014-0500-6 DO - 10.1007/s11910-014-0500-6 ID - Okamura2014 ER - TY - JOUR AU - Kozauer, N. AU - Katz, R. PY - 2013 DA - 2013// TI - Regulatory innovation and drug development for early-stage Alzheimer’s disease JO - N Engl J Med. VL - 368 UR - https://doi.org/10.1056/NEJMp1302513 DO - 10.1056/NEJMp1302513 ID - Kozauer2013 ER - TY - STD TI - Selkoe DJ. Alzheimer’s disease. Cold Spring Harb Perspect Biol. 2011;3. doi:10.1101/cshperspect.a004457. ID - ref14 ER - TY - JOUR AU - Ballatore, C. AU - Lee, V. M. AU - Trojanowski, J. Q. PY - 2007 DA - 2007// TI - Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders JO - Nat Rev Neurosci. VL - 8 UR - https://doi.org/10.1038/nrn2194 DO - 10.1038/nrn2194 ID - Ballatore2007 ER - TY - JOUR AU - Braak, H. AU - Zetterberg, H. AU - Tredici, K. AU - Blennow, K. PY - 2013 DA - 2013// TI - Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid JO - Acta Neuropathol. VL - 126 UR - https://doi.org/10.1007/s00401-013-1139-0 DO - 10.1007/s00401-013-1139-0 ID - Braak2013 ER - TY - JOUR AU - Iqbal, K. AU - Alonso, A. C. AU - Gong, C. X. AU - Khatoon, S. AU - Pei, J. J. AU - Wang, J. Z. PY - 1998 DA - 1998// TI - Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles JO - J Neural Transm. VL - 53 UR - https://doi.org/10.1007/978-3-7091-6467-9_15 DO - 10.1007/978-3-7091-6467-9_15 ID - Iqbal1998 ER - TY - JOUR AU - Rowe, C. C. AU - Ellis, K. A. AU - Rimajova, M. AU - Bourgeat, P. AU - Pike, K. E. AU - Jones, G. PY - 2010 DA - 2010// TI - Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging JO - Neurobiol Aging. VL - 31 UR - https://doi.org/10.1016/j.neurobiolaging.2010.04.007 DO - 10.1016/j.neurobiolaging.2010.04.007 ID - Rowe2010 ER - TY - JOUR AU - Sperling, R. A. AU - Aisen, P. S. AU - Beckett, L. A. AU - Bennett, D. A. AU - Craft, S. AU - Fagan, A. M. PY - 2011 DA - 2011// TI - Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease JO - Alzheimers Dement. VL - 7 UR - https://doi.org/10.1016/j.jalz.2011.03.003 DO - 10.1016/j.jalz.2011.03.003 ID - Sperling2011 ER - TY - JOUR AU - Jack, C. R. AU - Knopman, D. S. AU - Weigand, S. D. AU - Wiste, H. J. AU - Vemuri, P. AU - Lowe, V. PY - 2012 DA - 2012// TI - An operational approach to National Institute on Aging-Alzheimer’s Association criteria for preclinical Alzheimer disease JO - Ann Neurol. VL - 71 UR - https://doi.org/10.1002/ana.22628 DO - 10.1002/ana.22628 ID - Jack2012 ER - TY - JOUR AU - Schenk, D. AU - Barbour, R. AU - Dunn, W. AU - Gordon, G. AU - Grajeda, H. AU - Guido, T. PY - 1999 DA - 1999// TI - Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse JO - Nature. VL - 400 UR - https://doi.org/10.1038/22124 DO - 10.1038/22124 ID - Schenk1999 ER - TY - JOUR AU - Doody, R. S. AU - Thomas, R. G. AU - Farlow, M. AU - Iwatsubo, T. AU - Vellas, B. AU - Joffe, S. PY - 2014 DA - 2014// TI - Alzheimer’s Disease Cooperative Study Steering Committee; Solanezumab study group. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1312889 DO - 10.1056/NEJMoa1312889 ID - Doody2014 ER - TY - JOUR AU - Cummings, J. AU - Cho, W. AU - Ward, M. AU - Friesenhahn, M. AU - Brunstein, F. AU - Honigberg, L. PY - 2014 DA - 2014// TI - A randomized, double-blind, placebo-controlled phase 2 study to evaluate the efficacy and safety of crenezumab in patients with mild to moderate Alzheimer’s disease JO - Alzheimers Demen VL - 10 UR - https://doi.org/10.1016/j.jalz.2014.04.450 DO - 10.1016/j.jalz.2014.04.450 ID - Cummings2014 ER - TY - JOUR AU - Bohrmann, B. AU - Baumann, K. AU - Benz, J. AU - Gerber, F. AU - Huber, W. AU - Knoflach, F. PY - 2012 DA - 2012// TI - Gantenerumab: a novel human anti-beta-amyloid antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β JO - J Alzheimers Dis. VL - 28 ID - Bohrmann2012 ER - TY - JOUR AU - Haass, C. AU - Selkoe, D. J. PY - 2007 DA - 2007// TI - Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide JO - Nat Rev Mol Cell Biol. VL - 8 UR - https://doi.org/10.1038/nrm2101 DO - 10.1038/nrm2101 ID - Haass2007 ER - TY - CHAP AU - Forman, M. AU - Tseng, J. AU - Palcza, J. AU - Leempoels, J. AU - Ramael, S. AU - Krishna, G. PY - 2012 DA - 2012// TI - The novel BACE inhibitor MK-8931 dramatically lowers CSF beta-amyloid peptides in healthy subjects: results from a rising single dose study (PL02. 004) BT - 64th American Academy of Neurology Annual Meeting PB - Neurology CY - New Orleans ID - Forman2012 ER - TY - STD TI - Forman MS PJ, Tseng J, Dockendorf M, Canales C, Apter J, Backonja M, et al. The novel BACe inhibitor MK-8931 dramatically lowers CSF Abeta peptide in patients with mild to moderate Alzheimer’s disease. In: The 11th International Conference on Alzheimer’s and Parkinson’s Disease. Florence, Italy. 2013. ID - ref27 ER - TY - JOUR AU - Ryan, J. M. AU - Grundman, M. PY - 2009 DA - 2009// TI - Anti-amyloid-beta immunotherapy in Alzheimer’s disease: ACC-001 clinical trials are ongoing JO - J Alzheimer Dis. VL - 8 ID - Ryan2009 ER - TY - JOUR AU - Muhs, A. AU - Hickman, D. T. AU - Pihlgren, M. AU - Chuard, N. AU - Giriens, N. AU - Meerschman, C. PY - 2007 DA - 2007// TI - Liposomal vaccines with conformation-specific amyloid antigens define immune response and efficacy in APP transgenic mice JO - Proc Natl Acad Sci U S A. VL - 8 UR - https://doi.org/10.1073/pnas.0703137104 DO - 10.1073/pnas.0703137104 ID - Muhs2007 ER - TY - JOUR AU - Winblad, B. AU - Andreasen, N. AU - Minthon, L. AU - Floesser, A. AU - Imbert, G. AU - Dumortier, T. PY - 2012 DA - 2012// TI - Safety, tolerability, and antibody response of active beta-amyloid immunotherapy with CAD106 in patients with Alzheimer’s disease: randomized, double-blind, placebo-controlled, first-in-human study JO - Lancet Neurol. VL - 8 UR - https://doi.org/10.1016/S1474-4422(12)70140-0 DO - 10.1016/S1474-4422(12)70140-0 ID - Winblad2012 ER - TY - JOUR AU - Lemere, C. A. AU - Masliah, E. PY - 2010 DA - 2010// TI - Can Alzheimer disease be prevented by amyloid-beta immunotherapy? JO - Nat Rev Neurol. VL - 6 UR - https://doi.org/10.1038/nrneurol.2009.219 DO - 10.1038/nrneurol.2009.219 ID - Lemere2010 ER - TY - JOUR AU - Bateman, R. J. AU - Xiong, C. AU - Benzinger, T. L. AU - Fagan, A. M. AU - Goate, A. AU - Fox, N. C. PY - 2012 DA - 2012// TI - Dominantly Inherited Alzheimer Network Clinical and biomarker changes in dominantly inherited Alzheimer’s disease JO - N Engl J Med. VL - 367 UR - https://doi.org/10.1056/NEJMoa1202753 DO - 10.1056/NEJMoa1202753 ID - Bateman2012 ER - TY - JOUR AU - Sigurdsson, E. M. PY - 2009 DA - 2009// TI - Tau-focused immunotherapy for Alzheimer’s disease and related tauopathies JO - Curr Alzheimer Res. VL - 6 UR - https://doi.org/10.2174/156720509789207930 DO - 10.2174/156720509789207930 ID - Sigurdsson2009 ER - TY - JOUR AU - Asuni, A. A. AU - Boutajangout, A. AU - Quartermain, D. AU - Sigurdsson, E. M. PY - 2007 DA - 2007// TI - Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements JO - J Neurosci. VL - 27 UR - https://doi.org/10.1523/JNEUROSCI.2361-07.2007 DO - 10.1523/JNEUROSCI.2361-07.2007 ID - Asuni2007 ER - TY - JOUR AU - Hefti, F. PY - 1986 DA - 1986// TI - Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections JO - J Neurosci. VL - 6 ID - Hefti1986 ER - TY - JOUR AU - Rafii, M. S. AU - Baumann, T. L. AU - Bakay, R. A. AU - Ostrove, J. M. AU - Siffert, J. AU - Fleisher, A. S. PY - 2014 DA - 2014// TI - A phase 1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer’s disease JO - Alzheimers Dement. VL - 10 UR - https://doi.org/10.1016/j.jalz.2013.09.004 DO - 10.1016/j.jalz.2013.09.004 ID - Rafii2014 ER - TY - JOUR AU - Schmidt, A. M. AU - Sahagan, B. AU - Nelson, R. B. AU - Selmer, J. AU - Rothlein, R. AU - Bell, J. M. PY - 2009 DA - 2009// TI - The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer’s disease JO - Curr Opin Investig Drugs. VL - 10 ID - Schmidt2009 ER - TY - JOUR AU - Galasko, D. AU - Bell, J. AU - Mancuso, J. Y. AU - Kupiec, J. W. AU - Sabbagh, M. N. AU - Dyck, C. PY - 2014 DA - 2014// TI - Clinical trial of an inhibitor of RAGE-beta-amyloid interactions in Alzheimer disease JO - Neurology. VL - 82 UR - https://doi.org/10.1212/WNL.0000000000000364 DO - 10.1212/WNL.0000000000000364 ID - Galasko2014 ER - TY - JOUR AU - Burstein, A. H. AU - Grimes, I. AU - Galasko, D. R. AU - Aisen, P. S. AU - Sabbagh, M. AU - Mjalli, A. M. PY - 2014 DA - 2014// TI - Effect of TTP488 in patients with mild to moderate Alzheimer’s disease JO - BMC Neurol. VL - 14 UR - https://doi.org/10.1186/1471-2377-14-12 DO - 10.1186/1471-2377-14-12 ID - Burstein2014 ER - TY - JOUR AU - Prickaerts, J. AU - Goethem, N. P. AU - Chesworth, R. AU - Shapiro, G. AU - Boess, F. G. AU - Methfessel, C. PY - 2012 DA - 2012// TI - EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors JO - Neuropharmacology. VL - 62 UR - https://doi.org/10.1016/j.neuropharm.2011.10.024 DO - 10.1016/j.neuropharm.2011.10.024 ID - Prickaerts2012 ER - TY - JOUR AU - Miller, B. W. AU - Willett, K. C. AU - Desilets, A. R. PY - 2011 DA - 2011// TI - Rosiglitazone and pioglitazone for the treatment of Alzheimer’s disease JO - Ann Pharmacother. VL - 45 UR - https://doi.org/10.1345/aph.1Q238 DO - 10.1345/aph.1Q238 ID - Miller2011 ER - TY - JOUR AU - Shirazi, S. K. AU - Wood, J. G. PY - 1993 DA - 1993// TI - The protein tyrosine kinase, Fyn, in Alzheimer’s disease pathology JO - Neuroreport. VL - 4 UR - https://doi.org/10.1097/00001756-199304000-00024 DO - 10.1097/00001756-199304000-00024 ID - Shirazi1993 ER - TY - JOUR AU - Chin, J. AU - Palop, J. J. AU - Yu, G. Q. AU - Kojima, N. AU - Masliah, E. AU - Mucke, L. PY - 2004 DA - 2004// TI - Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice JO - J Neurosci. VL - 24 UR - https://doi.org/10.1523/JNEUROSCI.0277-04.2004 DO - 10.1523/JNEUROSCI.0277-04.2004 ID - Chin2004 ER - TY - JOUR AU - Lee, G. AU - Thangavel, R. AU - Sharma, V. M. AU - Litersky, J. M. AU - Bhaskar, K. AU - Fang, S. M. PY - 2004 DA - 2004// TI - Phosphorylation of tau by Fyn: implications for Alzheimer’s disease JO - J Neurosci. VL - 24 UR - https://doi.org/10.1523/JNEUROSCI.4162-03.2004 DO - 10.1523/JNEUROSCI.4162-03.2004 ID - Lee2004 ER -